WO2006105367A3 - Magnetically-labeled microparticles for oral drug delivery - Google Patents
Magnetically-labeled microparticles for oral drug delivery Download PDFInfo
- Publication number
- WO2006105367A3 WO2006105367A3 PCT/US2006/011832 US2006011832W WO2006105367A3 WO 2006105367 A3 WO2006105367 A3 WO 2006105367A3 US 2006011832 W US2006011832 W US 2006011832W WO 2006105367 A3 WO2006105367 A3 WO 2006105367A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- magnetically
- drug delivery
- oral drug
- labeled microparticles
- intestines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
Abstract
A pharmaceutically active agent is associated with a magnetic particle and formulated for oral administration. An externally imposed magnetic field retains the magnetic particle in the intestines, increasing the amount of the pharmaceutically active agent that passes from the intestines into the bloodstream.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66674005P | 2005-03-30 | 2005-03-30 | |
US60/666,740 | 2005-03-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006105367A2 WO2006105367A2 (en) | 2006-10-05 |
WO2006105367A3 true WO2006105367A3 (en) | 2006-12-28 |
Family
ID=37054160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/011832 WO2006105367A2 (en) | 2005-03-30 | 2006-03-30 | Magnetically-labeled microparticles for oral drug delivery |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006105367A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1970705A1 (en) * | 2007-03-15 | 2008-09-17 | Koninklijke Philips Electronics N.V. | Bead assisted analyte detection |
US20110237686A1 (en) | 2010-03-26 | 2011-09-29 | Cerulean Pharma Inc | Formulations and methods of use |
US9165703B2 (en) * | 2010-08-25 | 2015-10-20 | Brown University | Methods and systems for prolonged localization of drug delivery |
WO2016210098A1 (en) | 2015-06-24 | 2016-12-29 | Board Of Regents, The University Of Texas System | Dual assembly nanoparticles |
WO2017210543A1 (en) * | 2016-06-03 | 2017-12-07 | Tamarisk Technologies Group Llc | Compositions for oral administration of active agents |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4345588A (en) * | 1979-04-23 | 1982-08-24 | Northwestern University | Method of delivering a therapeutic agent to a target capillary bed |
US6004534A (en) * | 1993-07-23 | 1999-12-21 | Massachusetts Institute Of Technology | Targeted polymerized liposomes for improved drug delivery |
-
2006
- 2006-03-30 WO PCT/US2006/011832 patent/WO2006105367A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4345588A (en) * | 1979-04-23 | 1982-08-24 | Northwestern University | Method of delivering a therapeutic agent to a target capillary bed |
US6004534A (en) * | 1993-07-23 | 1999-12-21 | Massachusetts Institute Of Technology | Targeted polymerized liposomes for improved drug delivery |
Also Published As
Publication number | Publication date |
---|---|
WO2006105367A2 (en) | 2006-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS52367B (en) | Reduced volume formulation of glatiramer acetate and methods of administration | |
WO2006022996A3 (en) | Dosage form containing multiple drugs | |
WO2008130803A3 (en) | Pulmonary delivery of spherical insulin microparticles | |
WO2006124047A3 (en) | Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent | |
WO2007117661A3 (en) | Drug microparticles | |
WO2007146426A3 (en) | Nanoshells for drug delivery | |
WO2006125819A3 (en) | Oral microparticulate, anti-misuse drug formulation | |
WO2006008639A8 (en) | Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody | |
EP3248600B8 (en) | Combinations and modes of administration of therapeutic agents and combination therapy | |
EP2258362A3 (en) | Titration dosing regimen for controlled release tramadol | |
WO2007093642A3 (en) | Microparticulate pharmaceutical forms resistant to immediate release of the active principle in the presence of alcohol | |
WO2007103293A3 (en) | Ethanol-resistant sustained release formulations | |
WO2006105401A3 (en) | Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist | |
WO2007135193A3 (en) | Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means | |
WO2006002365A3 (en) | Microparticles with high loadings of a bioactive agent | |
WO2006026592A3 (en) | Oral administration of poorly absorbed drugs, methods and compositions related thereto | |
MXPA05007158A (en) | Pharmaceutical formulation with an insoluble active agent for pulmonary administration. | |
NZ588913A (en) | Liver cancer drug | |
PL1883387T3 (en) | Container for liquid medicaments to be administered | |
EP1781354A4 (en) | An occludable intravascular catheter for drug delivery and method of using the same | |
MX2009005696A (en) | Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application. | |
WO2006105367A3 (en) | Magnetically-labeled microparticles for oral drug delivery | |
TW200637611A (en) | Pharmaceutical for hygienic administration in the ear | |
WO2003075977A3 (en) | Agglomerated particles for aerosol drug delivery | |
TNSN05048A1 (en) | Inhalation compositions with high drug ratios |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06740147 Country of ref document: EP Kind code of ref document: A2 |